Indies Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INDIES PHARMA, and what generic and branded alternatives to INDIES PHARMA drugs are available?
INDIES PHARMA has one approved drug.
Drugs and US Patents for Indies Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indies Pharma | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 218054-001 | Aug 22, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.